POPULARITY
“Behind the Evidence” is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH). This episode was recorded in June 2024 and features an interview with Joao P. De Aquino, MD on his article published in the American Journal of Drug and Alcohol Abuse: “The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies.” And an interview with Donovan Maust, MD on his article in JAMA Network Open: “Benzodiazepine discontinuation and mortality among patients receiving long-term benzodiazepine therapy.” Click the following links to read AODH's summaries of Dr De Aquino and Dr. Maust's articles.Also discussed: Christine PJ, Lodi S, Hsu HE, et al. Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder. Addiction. 2024;119(7):1313-1321.Hosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel Silveira, MBAEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Medical Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MD.Learn more about AODH and subscribe for free at www.aodhealth.org“Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
“Behind the Evidence” is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH). This episode was recorded 24 June 2024 and features an interview with Ayesha Appa, MD on her recent publication in Drug and Alcohol Dependence: “Stimulant use and opioid-related harm in patients on long-term opioids for chronic pain.” Click here to read AODH's summary of Dr Appa's article. Hosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel Silveira, MBAEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Medical Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MDLearn more about AODH and subscribe for free at www.aodhealth.org“Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
“Behind the Evidence" is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH). This episode was recorded 15-16 March 2024 and features six short interviews with presenters at the first-annual Together for Hope Boston Addiction Conference:Miriam Komaromy, MD: Medical Director, Grayken Center for AddictionThe Civil Right to MOUD. Ruchi Shah, DO, Boston Medical Center, and Amelia Caramadre, JD, MPH, Kaplan and Grady LLCDecreasing Risk and Stigma Among Patients Who Use Drugs: Implementation of an ED-Based Harm Reduction Program. Karri Weisenthal, MD, Boston Medical CenterRecovering Safety: A Pilot Study of a Women's Empowerment Group for Survivors of Intimate Partner Violence with Substance Use Disorders. Amanda Sedgewick, DO, McLean HospitalHow can we make addiction treatment more appealing, effective, and equitable for Black patients? Corinne Beaugard, PhD, MSW, Post-Doctoral Research Fellow, Boston Medical CenterSubstance use and pain curriculum innovation: establishing a student-faculty partnership for lasting curricular change. Rory Vu Mather, MS, Harvard Medical SchoolHosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel Silveira, MBAEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Medical Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MDLearn more about AODH and subscribe for free at www.aodhealth.org“Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.***If you like BTE, you might also enjoy Addiction Practice Pod, a podcast of the British Columbia Centre on Substance Use about approaches to addiction and substance use care. Hosted by award-winning journalist David P. Ball and rotating clinical co-hosts, Addiction Practice Pod offers practical tips and guidance to health care providers seeking to improve their skills in addiction care. In the series, you'll hear from clinicians, policy makers, and people with lived and living experience of substance use. Topics range from considerations for alcohol withdrawal management to improving care for racialized people who use substances. Listen now wherever you listen to podcasts! Learn more: https://bcechoonsubstanceuse.ca/podcasts/
“Behind the Evidence” is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH). This episode was recorded 16 January 2024 and features an interview with Marie Jauffret-Roustide, PhD on her recent publication in Addiction: “Drug consumption rooms are effective to reduce at-risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study.” Click here to read AODH's summary of Dr Jauffret-Roustide's article. Hosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel Silveira, MBAEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Medical Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MD Learn more about AODH and subscribe for free at www.aodhealth.org “Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
“Behind the Evidence” is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH).This episode was recorded 11 July 2023 and features an interview with Dr Sumeet Singh-Tan, DO on her recent publication in Journal of General Internal Medicine: “Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder.” Click here to read AODH's summary of Dr Singh-Tan's recent publication.Hosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel Silveira, MBAEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Medical Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MDLearn more about AODH and subscribe for free at www.aodhealth.org“Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
“Behind the Evidence” is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH).This episode was recorded 18 May 2023 and features an interview with Dr Noa Krawczyk, PhD on her recent publication in The International Journal of Drug Policy: “Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019.” Click here to read AODH's summary of Dr Krawczyk's recent publication.Learn more about the Liberating Methadone conference.Read about the minimally disruptive OUD framework. Hosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel SilveiraEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Medical Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MDLearn more about AODH and subscribe for free at www.aodhealth.org“Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
“Behind the Evidence” is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH). This episode was recorded 12 April 2023 and features an interview with Dr Christopher M. Jones, PharmD, DrPH (director of the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention) on his recent publication in JAMA Psychiatry: “Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.” Click here to read AODH's summary of Dr Jones's recent publication. Hosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel SilveiraEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Medical Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MD Learn more about AODH and subscribe for free at www.aodhealth.org “Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
“Behind the Evidence” is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH). This episode was recorded 24 March 2023 and features an interview with Dr Ayana Jordan, MD, PhD on her recent research and work on racial and ethnic differences in substance use treatment. Click here to read AODH's summary of Dr Jordan's recent publication.Hosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel SilveiraEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Medical Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MDLearn more about AODH and subscribe for free at www.aodhealth.org“Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
“Behind the Evidence” is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH). This episode was recorded 11 November 2022 and features an interview with Jessica Taylor, MD on her recent research and work on a low-threshold methadone bridge clinic and linkage to opioid use disorder treatment. Read a summary of Dr Taylor's recent publication in AODH.Hosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel SilveiraEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Medical Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MDLearn more about AODH and subscribe for free at www.aodhealth.org“Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
While the effects of addiction on someone with a substance use disorder are often readily apparent, the impact on families is less understood and certainly under supported. Alicia Ventura, Director of Special Projects and Research for the Grayken Center for Addiction TTA Program at Boston Medical Center, joins us to share what families can do to positively affect the outcome for their loved one with a substance use disorder.
Todd Kerensky, MD, Director of Addicition Medicine Services at South Shore Health and Julie Paul, DNP,CNM,PMHNP-BC, Director, Perinatal Behavioral Health Program at South Shore Health discuss the new Grayken Center for Treatment at a new location at 797 Main Street, Weymouth, MA.
Michael Botticelli, Executive Director of the Grayken Center for Addiction, describes the state of the opioid epidemic, explains how policies changed in the eras of Obama and Trump, highlights bi-partisan efforts, and offers advice to the current generation of public health practitioners responding to the epidemic.
In the current era of the opioid epidemic, what role do opioid prescriptions play? With all the scrutiny physicians face when prescribing opioids, what can trainees do to be safe and thoughtful prescribers? Dr. Scott Hadland, Assistant Professor of Pediatrics at Boston University School of Medicine and on the faculty of the Grayken Center for...
Michael Botticelli, the Executive Director, Grayken Center for Addiction,and Paul Kusiak, a father of two children in recovery, share the struggles and burdens of addiction, and how the recent partnership with the Grayken Center for Addiction at Boston Medical Center will help parents and loved ones navigate through recovery.
Tom Hoffman from NASA explains the new mission of the Mars InSight Lander launching on Saturday. Nicolas Fabien-Ouellet from the Univ of Vermont talks cultural appropriation and poutine. The executive director of the Grayken Center for Addiction at Boston Medical Center, Michael Botticelli shares why the way we speak about "addicts" matters.
Guest: Michael Botticelli, director of the White House Office of National Drug Control Policy As director of national drug control policy, Michael Botticelli led the Obama administration’s efforts to advance reforms in prevention, criminal justice and treatment. He was also the first person in recovery from a substance use disorder to hold that position. Michael sat down with me at the Innovations in Recovery conference in San Diego to describe how the power of personal narrative can go beyond the reach of scientific data to influence widespread change in public attitudes and policy. For more about Recovery Unscripted, visit http://recoveryunscripted.org For more about Michael's work with the Grayken Center for Addiction, visit http://www.bmc.org/addiction. Music from this episode: "The Ache" by David Condos - URL: davidcondos.com "The Things We Save" by Podington Bear - URL: http://freemusicarchive.org/music/Podington_Bear/Piano_III_-_Minor_Keys/The_Things_We_Save - Composer: Chad Crouch "Sensitive" by Podington Bear - URL: http://freemusicarchive.org/music/Podington_Bear/Brooding/Sensitive - Composer: Chad Crouch "Frosted Glass" by Podington Bear - URL: http://freemusicarchive.org/music/Podington_Bear/Positive/FrostedGlass - Composer: Chad Crouch "Ronny" by Alex Fitch - URL: URL: freemusicarchive.org/music/Alex_Fit…ola/Ronny_1253
Michael Botticelli, who served as director of the Office of National Drug Control Policy in the Obama administration, says President Trump can't have it both ways — advocating more treatment for drug addiction while calling for repeal of the Affordable Care Act. The 2010 law defined addictions treatment as an “essential benefit” that must be covered through insurance policies. Not mentioning the effect ACA repeal would have on the nation’s response to the opioid crisis, Botticelli says, was a "glaring omission" of the Christie commission that called for a declaration of a national emergency.Botticelli now runs the Grayken Center for Addiction Medicine at Boston Medical Center. He is also now a distinguished policy scholar at the Johns Hopkins Bloomberg School of Public Health.Links:President Trump can't have it both ways
Michael Botticelli, “Drug Czar” under the Obama administration, joins us to talk about the opioid epidemic: what needs to be done, how he feels the current administration is handling it, and how his new role as Executive Director of the Grayken Center for Addiction Medicine puts him in a unique position to help make a change.
Addiction is the most pressing public health crisis of our time. It is a chronic, medical condition that can impair health and function and is characterized by repeated use of a substance despite harmful consequences.In this segment, Michael Botticelli, one of the nation's leading addiction experts, who served as the Director of National Drug Control Policy at the White House under President Obama and is currently the Director of Boston Medical Center's newly established Grayken Center for Addiction Medicine, joins the show to discuss how policy makers, clinicians, patients and families in crisis from across the country are turning to BMC because of its expertise and leadership in caring for patients with addiction. Among the busiest, most comprehensive treatment centers for behavioral health and addiction treatment in the country, BMC has established a formal Addiction Center to help turn the tide on this national crisis.
From policy makers to clinicians to patients and families in crisis, people across the country are turning to Boston Medical Center because of its expertise and leadership in caring for patients with addiction.Among the busiest, most comprehensive treatment centers for behavioral health and addiction treatment in the country, BMC has long been an epicenter of innovation, creating replicable care models in the field, providing training to those at the front lines of the opioid crisis sweeping the nation, and conducting research.Now, BMC has established the Grayken Center for Addiction Medicine. Listen as Alexander Y. Walley, MD and Jessica Gray, MD discuss the Grayken Center for Addiction Medicine as a way to help turn the tide on this national crisis. For More Information Please Visit: www.bmc.org/addictionmedicine